Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine

Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted Covid-19 vaccine, beginning in 2021.